A recent study also showed that in BC, direct targeting of WNT5A by miR-374a treatment inhibited the phosphorylation and nuclear translocation of β-catenin, thus decreasing the expression of BC stemness-related proteins and the aggressiveness behavior of BC [124]. The gene discussed is WNT5A; the disease is breast cancer.